ARYX THERAPEUTICS Financial Statements From 2010 to 2022

ARYX
 Stock
  

USD 0.0005  0.00  0.00%   

ARYX THERAPEUTICS financial statements provide useful quarterly and yearly information to potential ARYX THERAPEUTICS INC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on ARYX THERAPEUTICS financial statements helps investors assess ARYX THERAPEUTICS's valuation, profitability, and current liquidity needs.
ARYX THERAPEUTICS INC does not now have any fundamental signals for analysis.
.
  
Check ARYX THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ARYX THERAPEUTICS main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . ARYX THERAPEUTICS financial statements analysis is a perfect complement when working with ARYX THERAPEUTICS Valuation or Volatility modules. It can also supplement various ARYX THERAPEUTICS Technical models . Please continue to the analysis of ARYX THERAPEUTICS Correlation against competitors.

ARYX THERAPEUTICS Cash Flow from Operations Analysis

ARYX THERAPEUTICS's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Operating Cash Flow 
 = 
EBITDA 
-  
Taxes 
More About Cash Flow from Operations | All Equity Analysis

Current ARYX THERAPEUTICS Cash Flow from Operations

    
  (20.07 M)  
Most of ARYX THERAPEUTICS's fundamental indicators, such as Cash Flow from Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ARYX THERAPEUTICS INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
Compare to competition

In accordance with the recently published financial statements, ARYX THERAPEUTICS INC has (20.07 Million) in Cash Flow from Operations. This is 103.81% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The cash flow from operations for all United States stocks is 102.07% higher than that of the company.

ARYX THERAPEUTICS INC Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ARYX THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare ARYX THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ARYX THERAPEUTICS competition to find correlations between indicators driving ARYX THERAPEUTICS's intrinsic value. More Info.
ARYX THERAPEUTICS INC is the top company in current valuation category among related companies. It is number one stock in total asset category among related companies fabricating about  1.39  of Total Asset per Current Valuation. . Comparative valuation analysis is a catch-all model that can be used if you cannot value ARYX THERAPEUTICS by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ARYX THERAPEUTICS's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ARYX THERAPEUTICS's earnings, one of the primary drivers of an investment's value.

About ARYX THERAPEUTICS Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ARYX THERAPEUTICS income statement, its balance sheet, and the statement of cash flows. ARYX THERAPEUTICS investors use historical funamental indicators, such as ARYX THERAPEUTICS's revenue or net income, to determine how well the company is positioned to perform in the future. Although ARYX THERAPEUTICS investors may use each financial statement separately, they are all related. The changes in ARYX THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ARYX THERAPEUTICS's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ARYX THERAPEUTICS Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ARYX THERAPEUTICS. Please read more on our technical analysis and fundamental analysis pages.
ARYx Therapeutics, Inc. discovers and develops novel therapies for large, chronic, and oral markets. ARYx Therapeutics, Inc. was founded in 1997 and is based in Fremont, California. ARYX THERAPEUTICS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on PNK Exchange. It employs 56 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ARYX THERAPEUTICS in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ARYX THERAPEUTICS's short interest history, or implied volatility extrapolated from ARYX THERAPEUTICS options trading.

Pair Trading with ARYX THERAPEUTICS

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ARYX THERAPEUTICS position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARYX THERAPEUTICS will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to ARYX THERAPEUTICS could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ARYX THERAPEUTICS when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ARYX THERAPEUTICS - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ARYX THERAPEUTICS INC to buy it.
The correlation of ARYX THERAPEUTICS is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ARYX THERAPEUTICS moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ARYX THERAPEUTICS INC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ARYX THERAPEUTICS can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of ARYX THERAPEUTICS Correlation against competitors. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for analysis

When running ARYX THERAPEUTICS INC price analysis, check to measure ARYX THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ARYX THERAPEUTICS is operating at the current time. Most of ARYX THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of ARYX THERAPEUTICS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ARYX THERAPEUTICS's price. Additionally, you may evaluate how the addition of ARYX THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Is ARYX THERAPEUTICS's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ARYX THERAPEUTICS. If investors know ARYX THERAPEUTICS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ARYX THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
237.6 K
Return On Assets
(0.75) 
The market value of ARYX THERAPEUTICS INC is measured differently than its book value, which is the value of ARYX THERAPEUTICS that is recorded on the company's balance sheet. Investors also form their own opinion of ARYX THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is ARYX THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ARYX THERAPEUTICS's market value can be influenced by many factors that don't directly affect ARYX THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ARYX THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine ARYX THERAPEUTICS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ARYX THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.